• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Dips Over 550 Points; BJ's Wholesale Club Earnings Beat Views

    5/23/24 2:40:33 PM ET
    $BCYC
    $BJ
    $BNZI
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Department/Specialty Retail Stores
    Consumer Discretionary
    Get the next $BCYC alert in real time by email

    U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 550 points on Thursday.

    The Dow traded down 1.44% to 39,098.81 while the NASDAQ fell 0.39% to 16,735.32. The S&P 500 also fell, dropping, 0.69% to 5,270.47.

    Check This Out: How To Earn $500 A Month From Ross Stores Stock Ahead Of Q1 Earnings

    Leading and Lagging Sectors

    Information technology shares rose by 1.5% on Thursday.

    In trading on Thursday, real estate shares fell by 1.3%.

    Top Headline

    BJ's Wholesale Club Holdings, Inc. (NYSE:BJ) reported better-than-expected results for its first quarter on Thursday.

    The company posted quarterly revenue growth of 4.1% year-on-year to $4.918 billion, beating the analyst consensus estimate of $4.831 billion. Total comparable club sales increased by 1.6%. Adjusted EPS of 85 cents beat the analyst consensus estimate of 83 cents.

    Equities Trading UP
                           

    • OneMedNet Corporation (NASDAQ:ONMD) shares shot up 141% to $1.14 after the company highlighted a ‘five-fold expansion’ of its iRWD network and platform.
    • Shares of Bicycle Therapeutics plc (NASDAQ:BCYC) got a boost, surging 18% to $25.24 after the company announced a $555 million private placement equity financing.
    • e.l.f. Beauty, Inc. (NYSE:ELF) shares were also up, gaining 22% to $190.37 after the company reported better-than-expected fourth-quarter earnings.

    Equities Trading DOWN

    • Banzai International, Inc. (NASDAQ:BNZI) shares dropped 26% to $0.1698. Banzai announced pricing of $2.5 million public offering.
    • Shares of Cytokinetics, Incorporated (NASDAQ:CYTK) were down 16% to $49.71. Cytokinetics priced its public offering of 9,803,922 common stock at $51 per share.
    • Triumph Group, Inc. (NYSE:TGI) was down, falling 12% to $13.18 after the company reported fourth-quarter FY24 results.

    Also Check This Out: Jim Cramer Offers His Take On Corning, Calls This Healthcare Stock A ‘Terrific Spec’

    Commodities

    In commodity news, oil traded down 1.1% to $76.72 while gold traded down 2.4% at $2,336.30.

    Silver traded down 3.5% to $30.395 on Thursday, while copper fell 1.2% to $4.7885.

    Euro zone

    European shares were mixed today. The eurozone's STOXX 600 rose 0.07%, Germany's DAX rose 0.06% and France's CAC 40 gained 0.13%. Spain's IBEX 35 Index fell 0.16%, while London's FTSE 100 fell 0.37%.

    The HCOB Eurozone services PMI came in unchanged at 53.3 in May, while manufacturing PMI rose to 47.4 in May 2024, recording the highest level in 15 months.

    The S&P Global UK composite PMI fell to 52.8 in May, from 54.1 in April. The Germany composite PMI climbed to 52.2 in May, notching the strongest reading in a year. France composite PMI declined to 49.1 in May compared to 50.5 in the previous month.

    Asia Pacific Markets

    Asian markets closed mixed on Thursday, with Japan's Nikkei surging 1.26%, China's Composite Index dipping 1.33%, Hong Kong's Hang Seng Index falling 1.70% and India's S&P BSE Sensex gaining 1.36%.

    The annual inflation rate in Hong Kong eased to 1.1% in April versus 2% a month ago and compared to market estimates of 2.1%. The HSBC India composite PMI rose to 61.7 in May 2 from 61.5 a month ago. The au Jibun Bank Japan composite PMI increased to 52.4 in May from 52.3 a month ago.

    Economics

    • The Chicago Fed National Activity Index declined to -0.23 in April versus a revised reading of -0.04 in the prior month.
    • U.S. initial jobless claims declined by 8,000 to 215,000 in the week ending May 18, compared to market estimates of 220,000.
    • The S&P Global manufacturing PMI rose to 50.9 in May from 50 in April, while services PMI climbed to 54.8 in May from 51.3.
    • The S&P Global composite PMI jumped to 54.4 in May compared to 51.3 in April, and topping market estimates of 51.1.
    • Sales of new single-family houses fell 4.7% month-over-month to an annualized rate of 634K in April.
    • U.S. natural-gas supplies increased 78 billion cubic feet during the week ended May 17.

    Now Read This: Top 5 Financial Stocks You May Want To Dump In Q2

    Get the next $BCYC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BCYC
    $BJ
    $BNZI
    $CYTK

    CompanyDatePrice TargetRatingAnalyst
    Cytokinetics Incorporated
    $CYTK
    1/28/2026$87.00Overweight
    Barclays
    BJ's Wholesale Club Holdings Inc.
    $BJ
    1/28/2026$90.00Buy → Hold
    Jefferies
    e.l.f. Beauty Inc.
    $ELF
    1/23/2026$110.00Buy
    Citigroup
    BJ's Wholesale Club Holdings Inc.
    $BJ
    1/23/2026$100.00Buy → Hold
    Melius
    e.l.f. Beauty Inc.
    $ELF
    1/14/2026$110.00Buy
    Jefferies
    BJ's Wholesale Club Holdings Inc.
    $BJ
    1/8/2026Hold
    Deutsche Bank
    BJ's Wholesale Club Holdings Inc.
    $BJ
    1/7/2026$90.00Equal Weight → Underweight
    Barclays
    Cytokinetics Incorporated
    $CYTK
    12/18/2025$95.00Neutral → Buy
    Goldman
    More analyst ratings

    $BCYC
    $BJ
    $BNZI
    $CYTK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cytokinetics Announces European Commission Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

    European Commission Approval Based on Results of SEQUOIA-HCM First European Launch Expected in Germany in Q2 2026 SOUTH SAN FRANCISCO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that the European Commission (EC) has approved MYQORZO® (aficamten), 5 mg, 10 mg, 15 mg and 20 mg tablets for the treatment of symptomatic (New York Heart Association, NYHA, class II-III) obstructive hypertrophic cardiomyopathy (oHCM) in adult patients. MYQORZO is an allosteric and reversible inhibitor of cardiac myosin motor activity. In patients with oHCM, myosin inhibition with MYQORZO reduces cardiac contractility and consequently, left ventricular outfl

    2/17/26 7:30:00 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cytokinetics to Announce Fourth Quarter Results on February 24, 2026

    SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that it is scheduled to report fourth quarter results on February 24, 2026 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics' senior management will host a conference call at 4:30 PM Eastern Time to discuss financial results and provide business updates. The conference call will be simultaneously webcast and can be accessed from the Investors & Media section of Cytokinetics' website at www.cytokinetics.com or directly at the following link: Cytokinetics Q4 2025 Earnings Conference Call. An archived replay of the webcast will be available via Cytokinetics'

    2/12/26 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    OneMedNet Reports Record 2025 Bookings of $2.79 Million, Surpassing Prior Year by More Than 4.1X and Accelerating Subscription Transition

    MINNEAPOLIS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leader in AI-powered Real-World Data (RWD), today announced record bookings in 2025 of data-delivery agreements totaling $2.79 million of contract value, exceeding 2024 bookings by more than four times (4X). The milestone reflects increasing deal size, strong enterprise demand, and meaningful progress toward a recurring subscription model. The Company also provides an update on product offering heading into 2026. 2025 Booking Highlights Total Bookings: $2.79 million in contract value signed in 2025, 4.1X more than prior fiscal yearLarger Deal Sizes:

    2/12/26 9:00:00 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $BCYC
    $BJ
    $BNZI
    $CYTK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Yu Jeffrey converted options into 2,307,549 shares, bought $959,586 worth of shares (2,010,479 units at $0.48) and was granted 245,000 shares, increasing direct ownership by 165% to 7,326,223 units (SEC Form 4)

    4 - OneMedNet Corp (0001849380) (Issuer)

    11/26/25 9:56:08 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Chief Medical Officer Yu Jeffrey bought $8,929 worth of shares (9,540 units at $0.94) and was granted 230,769 shares, increasing direct ownership by 10% to 2,763,195 units (SEC Form 4)

    4 - OneMedNet Corp (0001849380) (Issuer)

    11/26/25 9:55:32 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Director Casaburi Eric bought $39,262 worth of shares (20,475 units at $1.92) and was granted 90,000 shares (SEC Form 4)

    4 - OneMedNet Corp (0001849380) (Issuer)

    11/26/25 9:54:45 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $BCYC
    $BJ
    $BNZI
    $CYTK
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Bicycle Therapeutics plc

    SCHEDULE 13G - BICYCLE THERAPEUTICS PLC (0001761612) (Subject)

    2/18/26 4:47:32 PM ET
    $BCYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cytokinetics Incorporated filed SEC Form 8-K: Other Events

    8-K - CYTOKINETICS INC (0001061983) (Filer)

    2/17/26 7:30:28 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Banzai International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Banzai International, Inc. (0001826011) (Filer)

    2/13/26 5:25:56 PM ET
    $BNZI
    Computer Software: Prepackaged Software
    Technology

    $BCYC
    $BJ
    $BNZI
    $CYTK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays resumed coverage on Cytokinetics with a new price target

    Barclays resumed coverage of Cytokinetics with a rating of Overweight and set a new price target of $87.00

    1/28/26 7:16:37 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BJ's Wholesale downgraded by Jefferies with a new price target

    Jefferies downgraded BJ's Wholesale from Buy to Hold and set a new price target of $90.00

    1/28/26 7:13:07 AM ET
    $BJ
    Department/Specialty Retail Stores
    Consumer Discretionary

    Citigroup initiated coverage on e.l.f. Beauty with a new price target

    Citigroup initiated coverage of e.l.f. Beauty with a rating of Buy and set a new price target of $110.00

    1/23/26 8:18:55 AM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    $BCYC
    $BJ
    $BNZI
    $CYTK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Financial Officer Felice Laura L. sold $881,580 worth of shares (8,400 units at $104.95), decreasing direct ownership by 9% to 80,074 units (SEC Form 4)

    4 - BJ's Wholesale Club Holdings, Inc. (0001531152) (Issuer)

    2/19/26 4:20:27 PM ET
    $BJ
    Department/Specialty Retail Stores
    Consumer Discretionary

    Director Farrell Matthew was granted 980 shares, increasing direct ownership by 20% to 5,820 units (SEC Form 4)

    4 - e.l.f. Beauty, Inc. (0001600033) (Issuer)

    2/17/26 4:17:47 PM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    New insider Farrell Matthew claimed ownership of 4,840 shares (SEC Form 3)

    3 - e.l.f. Beauty, Inc. (0001600033) (Issuer)

    2/17/26 4:16:15 PM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    $BCYC
    $BJ
    $BNZI
    $CYTK
    Leadership Updates

    Live Leadership Updates

    View All

    Cytokinetics and Olympic Gold Medalist Sydney McLaughlin-Levrone Team Up to Raise Awareness of the Whole-Person Impact of Hypertrophic Cardiomyopathy (HCM)

    "On Track with HCM" Features Practical Insights for Managing Everyday Life with the Disease, Inspired by the Experience with HCM of McLaughlin-Levrone's Father, Willie McLaughlin SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced the launch of "On Track with HCM," demonstrating the company's long-standing commitment to the HCM community. The campaign features four-time Olympic gold medalist Sydney McLaughlin-Levrone, and her father, three-time all-American track star, Willie McLaughlin, who suffered from the non-obstructive form of hypertrophic cardiomyopathy (HCM) for more than two decades before receiving a heart trans

    1/27/26 8:00:00 AM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    e.l.f. Lands at ULTA Beauty Mexico, Expanding Accessibility to the Best of Beauty for Every Eye, Lip, and Face

    e.l.f.'s presence is growing following successful market launch in 2024 e.l.f. Beauty (NYSE:ELF), the bold disruptor with a kind heart, continues to expand its e.l.f.iverse with its official launch at ULTA Beauty in Mexico, marking the next step of its partnership with the retailer. Beginning today, November 10, 2025, beauty enthusiasts in Mexico can explore the best of e.l.f. Cosmetics and e.l.f. SKIN at all ULTA Beauty stores across the country and on the retailer's e-commerce platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251109144964/en/e.l.f. continues to expand its e.l.f.iverse with its official launch at ULTA

    11/10/25 12:01:00 AM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    Jamieson Wellness Inc. Announces Appointment of New Board Director

    Global CPG and tech executive brings more than 25 years of digital expertise to support the Company's growing e-commerce opportunities Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today the appointment of Gayle Tait to the Company's Board of Directors. "The VMS marketplace is experiencing a shift towards digital and social ecommerce globally," said Tim Penner, Chair of the Board of Jamieson Wellness. "As consumers continue to seek out digital communities to support their health and wellness journeys, understanding this rapidly growing and changing environment is crucial to growing with them. "Gayle has an impressive track record of driving enterpr

    10/21/25 4:05:00 PM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    $BCYC
    $BJ
    $BNZI
    $CYTK
    Financials

    Live finance-specific insights

    View All

    Cytokinetics to Announce Fourth Quarter Results on February 24, 2026

    SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that it is scheduled to report fourth quarter results on February 24, 2026 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics' senior management will host a conference call at 4:30 PM Eastern Time to discuss financial results and provide business updates. The conference call will be simultaneously webcast and can be accessed from the Investors & Media section of Cytokinetics' website at www.cytokinetics.com or directly at the following link: Cytokinetics Q4 2025 Earnings Conference Call. An archived replay of the webcast will be available via Cytokinetics'

    2/12/26 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BJ's Wholesale Club Announces Fourth Quarter Fiscal 2025 Earnings Conference Call Date

    BJ's Wholesale Club Holdings, Inc. (NYSE:BJ), a leading operator of membership warehouse clubs, today announced that it will release financial results for the fourth quarter fiscal 2025 prior to the market open on Thursday, March 5, 2026 and will hold a conference call on the same day at 8:30 a.m. ET to discuss its financial performance. The live audio webcast of the call can be accessed under the "Events & Presentations" section of the company's investor relations website at https://investors.bjs.com. The webcast replay will remain available for one year. Participants may also dial (833) 470-1428 within the U.S. or +1 (929) 526-1599 outside the U.S. and reference conference ID 006082.

    1/27/26 6:45:00 AM ET
    $BJ
    Department/Specialty Retail Stores
    Consumer Discretionary

    Chattanooga Families Can Save at BJ's Wholesale Club Starting January 30

    Tennessee's newest club marks BJ's sixth location in the state BJ's Wholesale Club (NYSE:BJ) announced today that its location in Chattanooga, Tennessee, will open on January 30. The new club, located at 401 Northgate Mall Drive, is the sixth BJ's location in Tennessee. The on-site BJ's Gas station offers everyday low fuel prices and potential extra savings through BJ's Fuel Savers Program. The gas station opened on January 14. BJ's offers unbeatable value on everyday essentials in a convenient one-stop shop. Members save on fresh foods, produce, full-service deli items, fresh bakery goods, household essentials, home décor, pet supplies, toys, consumer electronics and more. BJ's membe

    1/22/26 6:45:00 AM ET
    $BJ
    Department/Specialty Retail Stores
    Consumer Discretionary

    $BCYC
    $BJ
    $BNZI
    $CYTK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Bicycle Therapeutics plc

    SC 13D/A - BICYCLE THERAPEUTICS PLC (0001761612) (Subject)

    12/17/24 6:46:27 PM ET
    $BCYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Bicycle Therapeutics plc

    SC 13G/A - BICYCLE THERAPEUTICS PLC (0001761612) (Subject)

    11/14/24 5:46:12 PM ET
    $BCYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Bicycle Therapeutics plc

    SC 13G/A - BICYCLE THERAPEUTICS PLC (0001761612) (Subject)

    11/14/24 4:32:50 PM ET
    $BCYC
    Biotechnology: Pharmaceutical Preparations
    Health Care